Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $164 | $56 | $141 | $233 |
| Short-Term Investments | $209 | $317 | $216 | $156 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $5 | $8 | $3 |
| Total Curr. Assets | $378 | $378 | $364 | $392 |
| Property Plant & Equip (Net) | $83 | $88 | $78 | $72 |
| Goodwill | $39 | $39 | $39 | $31 |
| Intangibles | $25 | $25 | $26 | $0 |
| Long-Term Investments | $0 | $34 | $43 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $150 | $188 | $188 | $105 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $528 | $566 | $552 | $497 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $3 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $38 | $46 | $37 | $20 |
| Total Curr. Liab. | $41 | $49 | $39 | $22 |
| LT Debt | $23 | $22 | $20 | $20 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $3 | $3 | $0 |
| Total NC Liab. | $24 | $25 | $23 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $25 | $25 | $23 | $23 |
| Total Liabilities | $64 | $74 | $62 | $42 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$1,218 | -$959 | -$714 | -$492 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $1,680 | $1,451 | $1,203 | $946 |
| Total Equity | $463 | $493 | $490 | $455 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $528 | $566 | $552 | $497 |
| Net Debt | -$138 | -$31 | -$118 | -$210 |